How big is Procaps Group SA?

As of Jun 18, Procaps Group SA has a market capitalization of 2,580.59 million, with net sales of 414.10 million and a net profit of 52.20 million over the latest four quarters. The balance sheet as of Dec 22 shows shareholder's funds of -0.94 million and total assets of 460.19 million.

As of Jun 18, Procaps Group SA has a market capitalization of 2,580.59 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the company reported net sales of 414.10 million for the latest four quarters and a net profit of 52.20 million during the same period.<BR><BR>As of Dec 22, the balance sheet shows shareholder's funds of -0.94 million and total assets of 460.19 million.

What does Procaps Group SA do?

Procaps Group SA is a micro-cap company in the Pharmaceuticals & Biotechnology industry, with recent net sales of $118 million and a net profit of $8 million as of September 2023. It has a market cap of $2.58 billion and key metrics include a P/E ratio of 5.00 and a debt-to-equity ratio of 6.92.

Overview:<BR>Procaps Group SA operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 118 Million (Quarterly Results - Sep 2023)<BR>Most recent Net Profit: 8 Million (Quarterly Results - Sep 2023)<BR>Market-cap: USD 2,580.59 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 5.00<BR>Debt Equity: 6.92<BR>Return on Equity: 10.83%<BR>Price to Book: 65.52<BR><BR>Contact Details:<BR>Address: 1425 BRICKELL AVE, #57B, MIAMI FL: 33131<BR>Tel: 1 212 9810630

Should I buy, sell or hold Procaps Group SA?

Is Procaps Group SA overvalued or undervalued?

As of September 7, 2023, Procaps Group SA is considered a very attractive investment due to its undervaluation indicated by a P/E ratio of 5, a Price to Book Value of 0.59, and a PEG ratio of 0.05, despite a 44.76% decline in stock performance over the past year.

As of 7 September 2023, the valuation grade for Procaps Group SA has moved from attractive to very attractive. The company is currently undervalued, as indicated by its P/E ratio of 5, a Price to Book Value of 0.59, and an EV to EBITDA of 5.77. In comparison, peers such as Harrow, Inc. show a significantly negative P/E of -52.05 and an EV to EBITDA of 60.41, while Oculis Holding AG does not qualify with a P/E of -14.96.<BR><BR>The PEG ratio for Procaps Group SA stands at an impressive 0.05, suggesting strong growth potential relative to its price. Additionally, the company's ROCE and ROE are both at 10.83%, indicating efficient use of capital. Despite the recent stock performance showing a decline of 44.76% over the past year compared to a 10.26% increase in the S&P 500, the valuation metrics suggest that Procaps Group SA presents a compelling investment opportunity at its current price of 1.45.

Is Procaps Group SA technically bullish or bearish?

As of August 27, 2025, Procaps Group SA's trend is mildly bearish, with daily moving averages and weekly Bollinger Bands indicating weakness, despite some bullish signals from the MACD and KST, and it has underperformed the S&P 500 with a year-to-date return of -52.14%.

As of 27 August 2025, the technical trend for Procaps Group SA has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by daily moving averages indicating a bearish trend and weekly Bollinger Bands also showing bearish signals. While the MACD is mildly bullish on both weekly and monthly time frames, the overall indicators suggest weakness. The KST shows a bullish signal weekly but is bearish monthly, and Dow Theory indicates a bearish trend weekly with no trend monthly. In terms of performance, Procaps has significantly underperformed the S&P 500 across all periods, with a year-to-date return of -52.14% compared to the S&P's 12.22%.